SV40 T1-mRNA trans-splicing and translation requires that the in vitro synthesized cRNA is capped before microinjection

The purpose of this investigation was to study the effect on cap structure for trans-splicing in mammalian cells. The early SV40 Bst/Bam pre-mRNA (cRNA) was synthesized in vitro in both capped (cap-Bst/Bam-cRNA) and non-capped (Bst/Bam-cRNA) versions and microinjected into the nuclei of TC7 cells. T...

Full description

Saved in:
Bibliographic Details
Published inFEBS letters Vol. 394; no. 2; pp. 233 - 236
Main Authors Graessmann, M., Eul, J., Berg, B., Zimmermann, C., Graessmann, A.
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 30.09.1996
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this investigation was to study the effect on cap structure for trans-splicing in mammalian cells. The early SV40 Bst/Bam pre-mRNA (cRNA) was synthesized in vitro in both capped (cap-Bst/Bam-cRNA) and non-capped (Bst/Bam-cRNA) versions and microinjected into the nuclei of TC7 cells. Trans-splicing was monitored by immunofluorescence staining (T1-antigen) and by RT-PCR analysis. Cap-Bst/Bam-cRNA was trans-spliced with high efficiency, but not the Bst/Bam-cRNA molecules. Northern blot analysis revealed that both the capped and uncapped cRNA molecules had similar stability in the microinjected cells. The coinjected m 7G(5′)ppp(5′)G cap analog did not inhibit the trans-splicing reaction in vivo and did not prevent nuclear export of the mRNA.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0014-5793
1873-3468
DOI:10.1016/0014-5793(96)00956-8